Drug Delivery

Intradigm Announces Addition of Samuel Zalipsky to Management Team

Published in Law and Health Weekly, June 16th, 2007

Intradigm Corporation, a leading developer of targeted and effective RNA interference (RNAi) therapeutics, announced the appointment of Samuel Zalipsky, Ph.D., as vice president, technology development. Dr. Zalipsky brings more than 20 years of experience in the pharmaceutical and biotechnology industry and offers significant expertise in areas critical to Intradigm's growth.

Dr. Zalipsky comes to Intradigm following an eight-year tenure with ALZA Corporation, a member of the Johnson & Johnson family of companies, during which he established himself as a leading expert on drug delivery systems. His broad drug delivery expertise spans several important areas including...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Law and Health Weekly

Source: Law and Health Weekly (2007-06-16)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry